Yokoyama Akira, Brooks Philip J, Yokoyama Tetsuji, Mizukami Takeshi, Matsui Toshifumi, Kimura Mitsuru, Matsushita Sachio, Higuchi Susumu, Maruyama Katsuya
National Hospital Organization Kurihama Medical and Addiction Center, Kanagawa, Japan.
Laboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Rockville, Maryland.
Alcohol Clin Exp Res. 2016 Mar;40(3):507-17. doi: 10.1111/acer.12983. Epub 2016 Feb 25.
Roughly 40% of East Asians have inactive aldehyde dehydrogenase-2 (ALDH2) encoded by the ALDH22 allele, and 90% have highly active alcohol dehydrogenase-1B (ADH1B) encoded by the ADH1B2 allele. Macrocytosis and macrocytic anemia in alcoholics have been associated with ADH1B and ALDH2 gene variants which increase acetaldehyde (AcH) levels.
We investigated the relationship between ADH1B2, ALDH22, and leukocyte counts of Japanese alcoholic men (N = 1,661).
After adjusting for age, drinking habits, smoking habits, body mass index, presence of liver cirrhosis, and serum levels of C-reactive protein, we found that total and differential leukocyte counts were lower in the presence of the ALDH21/2 genotype (vs. ALDH21/1 genotype). ALDH22/2 carriers were not found in our study population. Leukocyte, granulocyte, and monocyte counts were also lower in the presence of ADH1B2 (vs. ADH1B1/1 genotype), but the lymphocyte count was higher. The ALDH21/2 genotype was associated with leukocytopenia (<4,000/μl; adjusted odds ratio [95% confidence interval] = 1.89 [1.27 to 2.80]), granulocytopenia (<2,000/μl; 1.86 [1.22 to 2.82]), monocytopenia (<250/μl; 2.22 [1.49 to 3.29]), and lymphocytopenia (<1,000/μl; 1.93 [1.32 to 2.83]). In contrast, the ADH1B2 had the opposite effect on lymphocytopenia (0.65 [0.46 to 0.93]). Considering genotype effects under conditions of immune stimulation, we observed suppressive effects of ADH1B2 allele on leukocytosis (≥9,000/μl; 0.69 [0.50 to 0.97]), granulocytosis (≥6,500/μl; 0.66 [0.47 to 0.93]), and monocytosis (≥750/μl; 0.56 [0.39 to 0.79]). The ADH1B2 plus ALDH2*1/*2 combination had the greatest suppressive effects on the leukocyte, granulocyte, and monocyte counts.
The total and differential blood leukocyte counts of Japanese alcoholics were strongly affected by their ADH1B and ALDH2 gene variants. High AcH exposure levels probably play a critical role in the suppression of blood leukocyte counts in alcoholics.
大约40%的东亚人具有由ALDH22等位基因编码的无活性醛脱氢酶-2(ALDH2),90%的人具有由ADH1B2等位基因编码的高活性乙醇脱氢酶-1B(ADH1B)。酒精性肝病患者的大细胞性贫血与ADH1B和ALDH2基因变异有关,这些变异会增加乙醛(AcH)水平。
我们调查了日本男性酒精性肝病患者(N = 1661)中ADH1B2、ALDH22与白细胞计数之间的关系。
在调整年龄、饮酒习惯、吸烟习惯、体重指数、肝硬化的存在以及血清C反应蛋白水平后,我们发现存在ALDH21/2基因型(相对于ALDH21/1基因型)时,总白细胞计数和分类白细胞计数较低。在我们的研究人群中未发现ALDH22/2携带者。存在ADH1B2(相对于ADH1B1/1基因型)时,白细胞、粒细胞和单核细胞计数也较低,但淋巴细胞计数较高。ALDH21/2基因型与白细胞减少症(<4000/μl;调整后的优势比[95%置信区间]=1.89[1.27至2.80])、粒细胞减少症(<2000/μl;1.86[1.22至2.82])、单核细胞减少症(<250/μl;2.22[1.49至3.29])和淋巴细胞减少症(<1000/μl;1.93[1.32至2.83])相关。相比之下,ADH1B2对淋巴细胞减少症有相反的影响(0.65[0.46至0.93])。考虑到免疫刺激条件下的基因型效应,我们观察到ADH1B2等位基因对白细胞增多症(≥9000/μl;0.69[0.50至0.97])、粒细胞增多症(≥6500/μl;0.66[0.47至0.93])和单核细胞增多症(≥750/μl;0.56[0.39至0.79])有抑制作用。ADH1B2加ALDH2*1/*2组合对白细胞、粒细胞和单核细胞计数的抑制作用最大。
日本酒精性肝病患者的全血和分类白细胞计数受其ADH1B和ALDH2基因变异的强烈影响。高AcH暴露水平可能在酒精性肝病患者血液白细胞计数的抑制中起关键作用。